New Enterprise Associates 12 Limited Partnership 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-10 9:40 pm Unchanged | 2020-08-11 | 13D | Viracta Therapeutics, Inc. VIRX | New Enterprise Associates 12 Limited Partnership | 0 0.000% | 0 (Unchanged) | Filing |